Leurs R, Blandina P, Tedford C, Timmerman H
Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Vrije Universiteit, The Netherlands.
Trends Pharmacol Sci. 1998 May;19(5):177-83. doi: 10.1016/s0165-6147(98)01201-2.
The histamine H3 receptor was discovered 15 years ago, and many potent and selective H3 receptor agonists and antagonists have since been developed. Currently, much attention is being focused on the therapeutic potential of H3 receptor ligands. In this review, Rob Leurs, Patrizio Blandina, Clark Tedford and Henk Timmerman describe the available H3 receptor agonists and antagonists and their effects in a variety of pharmacological models in vitro and in vivo. The possible therapeutic applications of the various compounds are discussed.
组胺H3受体于15年前被发现,自那时起已开发出许多强效且选择性的H3受体激动剂和拮抗剂。目前,人们正高度关注H3受体配体的治疗潜力。在这篇综述中,罗布·勒斯、帕特里齐奥·布兰迪纳、克拉克·特德福德和亨克·蒂默曼描述了现有的H3受体激动剂和拮抗剂及其在多种体外和体内药理学模型中的作用。文中还讨论了各种化合物可能的治疗应用。